Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

By sjmartinez • January 3, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. PMID: 39748218.

Tags: Cabotegravir, HIV prevention, Infectious Diseases, long‐acting, pregnancy, PrEP, Publications, Women

Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium

Zaman F, Zhu X, Hunt JH, Rozek G, Eby Y, Hussain S, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock[...]

The life cycle of infection prevention and antimicrobial stewardship projects and interventions: the dynamic interplay of implementation and de-implementation science (Part I of II)

Branch-Elliman W, Chambers DA, Albin O, Batshon L, Castejon-Ramirez S, Cheng VC, Emetuche N, Datta R, Kamboj M, Krein SL, Staub M, Dassum SR, Rittmann[...]

Leveraging de-implementation science to promote infection prevention and stewardship: a roadmap and practical examples (Part II of II)

Branch-Elliman W, Reyes Dassum S, Stroever S, Albin O, Batshon L, Castejon-Ramirez S, Cheng VC, Emetuche N, Datta R, Kamboj M, Krein SL, Staub M,[...]